Table 1.

Demographic and Clinical Characteristics of Study Group (n = 263)

Characteristics	Value
Age, y	9.7 ± 4.1
Age group, y, n
0–4	14% (37)
5–9	37% (96)
10–14	40% (106)
15–18	9% (24)
Gender (% male), n	59% (155)
Race, white/black/other, %	94/5/1
BMI percentile at onset	51.3 ± 34.5
BMI Z score at onset	−0.0 ± 1.5
BMI percentile at 3 mo	73.2 ± 22.4a
BMI Z score at 3 mo	0.8 ± 0.9a
Waist class at 3 mo, % >75th percentile, n	67% (129)
Height Z score at 3 mo	0.4 ± 1.0b
WHtR at 3 mo	0.5 ± 0.1c
Centrally obese, %, n	30% (57)
C-peptide at onset, ng/mL	0.6 [0.2, 0.9]d
C-peptide at 3 mo, ng/mL	1.4 [0.7, 2.5]e
HbA1c at onset, %	11.7 ± 2.5
HbA1c at 3 mo, %	7.4 ± 0.8
HLA DQ2 and DQ8, %, n
XX	17% (41)
DQ2	30% (72)
DQ8	36% (89)
DQ2/DQ8	17% (42)
ICA h, % positive, n	84% (222)
GAD-65, % positive, n	56% (148)
IA2, % positive, n	73% (193)
IAA, % positive, n	64% (68)

Data are mean ± SD unless otherwise noted. C-peptide is presented as median [interquartile range].

^aBased on 247 subjects.

^bBased on 253 subjects.

^cBased on 192 subjects.

^dBased on 244 subjects.

^eBased on 219 subjects.